Welcome to Paid Research Studies

  • Conditions:   Intestinal Microbiome;   Febrile Neutropenia
    Interventions:   Drug: Piperacillin-tazobactam;   Drug: cefepime
    Sponsor:   Memorial Sloan Kettering Cancer Center

  • Condition:   Acute Respiratory Failure With Hypoxia
    Sponsor:   Columbia University

  • Conditions:   Perforated Appendicitis;   Postoperative Infection
    Intervention:   Drug: piperacillin-tazobactam
    Sponsor:   Phoenix Children's Hospital

  • Condition:   Appendicitis
    Interventions:   Drug: Piperacillin/Tazobactam;   Procedure: Surgical Treatment
    Sponsor:   NYU Langone Health

  • Condition:   Drug Effect
    Interventions:   Drug: piperacillin-tazobactam;   Drug: Cefazolin
    Sponsor:   Boston Children’s Hospital

  • Condition:   Graft-versus-host Disease Prevention
    Interventions:   Other: Best Practice;   Procedure: Fecal Microbiota Transplantation;   Drug: Nystatin;   Drug: Piperacillin-Tazobactam
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Not yet recruiting

  • Condition:   Other Infectious Diseases
    Interventions:   Drug: Cefepime;   Drug: Ceftolozane;   Other: Laboratory Biomarker Analysis;   Drug: Meropenem;   Drug: Piperacillin-Tazobactam;   Drug: Tazobactam
    Sponsors:   M.D. Anderson Cancer Center;   Merck Sharp & Dohme Corp.;   National Cancer Institute (NCI)

  • Conditions:   Open Fracture;   Post-Op Wound Infection
    Interventions:   Drug: Ceftriaxone;   Drug: Ampicillin/sulbactam;   Drug: Piperacillin/tazobactam;   Drug: Cefazolin + Gentamicin;   Drug: Clindamycin + Gentamicin
    Sponsor:   Mercy Health Ohio

  • Conditions:   Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Diseases
    Interventions:   Drug: Cefoxitin;   Drug: Piperacillin-tazobactam
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Indiana University;   Massachusetts General Hospital;   Thomas Jefferson University;   Washington University School of Medicine;   Advocate Illinois Masonic Medical Center;   Baptist Memorial Health Care Corporation;   Baylor Scott and White Health;   The Cleveland Clinic;   Emory University;   Fox Chase Cancer Center;   Gundersen Lutheran Medical Center;   Hackensack Meridian Health;   Hamilton Health Sciences Center;   Intermountain Health Care, Inc.;   Jersey Shore Medical Center (Hackensack Meridian);   Johns Hopkins University;   Montefiore Medical Center/Albert Einstein College of Medicine;   NorthShore University HealthSystem;   Milton S. Hershey Medical Center;   Rhode Island Hospital;   Stony Brook Medicine;   Sunnybrook Health Sciences Centre, Canada;   Temple University;   The Ohio State University Wexner Medical Center;   The Ottowa Hospital/University of Ottowa;   University of California, Davis;   University of Chicago;   University of Iowa;   University of Texas Southwestern Medical Center;   University of Utah;   University of Wisconsin, Madison;   Providence Health & Services;   Albany Medical College;   Northwestern University;   Universtiy of Mississippi Medical Center;   Mount Sinai Hospital, New York;   Brody School of Medicine at East Carolina University

  • Condition:   Urinary Tract Infections
    Interventions:   Drug: cefepime/AAI101 combination;   Drug: Piperacillin/tazobactam
    Sponsors:   Allecra;   Medpace, Inc.

  • Condition:   Osteomyelitis
    Interventions:   Drug: oral antibiotics;   Procedure: intravenous antibiotics
    Sponsors:   Julio Ramirez;   University of Louisville

  • Conditions:   Adenovirus;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Herpes Simplex Virus;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Treatment-resistant Schizophrenia;   Urinary Tract Infections;   Withdrawal;   Sepsis;   Gram-negative Infection;   Bradycardia;   Cardiac Arrest;   Cardiac Arrhythmia;   Staphylococcal Infections;   Nosocomial Pneumonia;   Neuromuscular Blockade;   Methicillin Resistant Staphylococcus Aureus;   Endocarditis;   Neutropenia;   Headache;   Fibrinolytic Bleeding;   Pulmonary Arterial Hypertension;   CMV Retinitis;   Hypertension;   Chronic Kidney Diseases;   Hyperaldosteronism;   Hypokalemia;   Heart Failure;   Hemophilia;   Heavy Menstrual Bleeding;   Insomnia
    Intervention:   Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
    Sponsors:   Daniel Benjamin;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The Emmes Company, LLC